Company Announcement Avecho’s Phase III Clinical Trial for Insomnia Commences March 26, 2024March 26, 2024
Company Announcement Avecho completes meeting with TGA confirming pathway for Phase III Clinical Trial March 14, 2024March 14, 2024
Company Announcement Ethics Approval for amendments to Phase III Clinical Trial March 7, 2024March 7, 2024
Company Announcement Avecho reaches two-year stability milestone for its CBD softgel capsule June 22, 2023June 22, 2023